These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11344823)

  • 1. The future of treatment for systemic lupus erythematosus.
    Alarcón-Segovia D
    Isr Med Assoc J; 2001 Feb; 3(2):127-30. PubMed ID: 11344823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor AE
    Arthritis Res Ther; 2003; 5(5):207-9. PubMed ID: 12932278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular therapy of systemic lupus erythematosus.
    Tyndall A
    Lupus; 2009 Apr; 18(5):387-93. PubMed ID: 19318389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.
    Driver CB; Ishimori M; Weisman MH
    Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Marmont A; Arnold R; Heipe F; Firestein GS; Carrier E; Hahn B; Barr W; Oyama Y; Snowden J; Kalunian K; Traynor A
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S49-51. PubMed ID: 12931242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive and immunomodulator treatment of severe systemic lupus].
    Guillevin L
    Ann Med Interne (Paris); 1996; 147(7):498-505. PubMed ID: 9092361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE).
    Kamrava MR; Anderson EM; Kalunian K; Bashey A; Holman P; Medina B; Ball ED; Carrier E
    Bone Marrow Transplant; 2005 Jan; 35(2):205-6. PubMed ID: 15543199
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
    Grimaldi CM
    Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!
    Karim MY; Pisoni CN; Khamashta MA
    Rheumatology (Oxford); 2009 Apr; 48(4):332-41. PubMed ID: 19155279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
    Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
    Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapies in systemic lupus erythematosus.
    Solsky MA; Wallace DJ
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):293-312. PubMed ID: 12041955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
    Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
    Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of systemic lupus erythematosus].
    Ivanova MM
    Klin Med (Mosk); 1985 Jan; 63(1):16-23. PubMed ID: 3887016
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.